Results 1 to 10 of about 776,178 (268)

Difficult case of differential diagnosis of partial lung atelectasis. Case report

open access: yesТерапевтический архив, 2023
In December 2018 the patient over 60 years old sought medical help with complaints of persistent cough. Based on computed tomography data there were identified the sings (symptoms) of right lung lower lobe atelectasis.
Olga M. Gordeeva   +6 more
doaj   +1 more source

Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis

open access: yesJournal of Immunology Research, 2022
Objective. Multidrug-resistant tuberculosis (MDR-TB) causes persistent infection and challenges tuberculosis control worldwide. T cell-mediated immunity plays a critical role in controlling Mycobacterium tuberculosis (Mtb) infection, and therefore ...
Peijun Tang   +17 more
doaj   +1 more source

Epidemiology of latent tuberculosis infection in Japan-born and foreign-born children in Japan

open access: yesWestern Pacific Surveillance and Response, 2023
Objective: This study aims to compare the epidemiology of notifications of latent tuberculosis infection (LTBI) among Japan-born and foreign-born children in Japan between 2010 and 2020, and to assess the language used during LTBI case interviews with ...
Saori Kasuya   +4 more
doaj   +1 more source

Tuberculosis and COVID-19 in Children and Adolescents. Two Waves of the Pandemic: Experiences and Conclusions

open access: yesТуберкулез и болезни лёгких, 2022
The objective of the study: to investigate diagnostics, course and outcomes of COVID-19 in children and adolescents with tuberculosis in relation to the epidemic control activities.Subjects and Methods: during the pandemic of coronavirus infection (the ...
E. S. Ovsyankina   +5 more
doaj   +1 more source

Effect of CFP-10/ESAT-6 secretory proteins on long-term non-specific immunological memory in mouse macrophages

open access: yesМедицинская иммунология, 2023
Innate immune cells (monocytes/macrophages, NK) can also develop immune memory, which means that these cells are trained after their first encounter with pathogens so that they exhibit a nonspecific immunological response to the same or another pathogen.
А. P. Lykov   +5 more
doaj   +1 more source

Successful treatment of advanced tuberculosis of a single lung with staged correction of post-pneumonectomy syndrome

open access: yesВестник хирургии имени И.И. Грекова, 2021
An observation from practice is given – surgical treatment of a patient with advanced tuberculosis of a single lung and a pronounced lung displacement. Patient A., 47 years old, after 3 months from the left pneumonectomy for fibrocavernous tuberculosis ...
R. V. Tarasov   +5 more
doaj   +1 more source

Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases

open access: yesТерапевтический архив, 2023
Progressive pulmonary fibrosis is a major problem in respiratory medicine. Currently, there are no reliable biomarkers for early diagnosis of progressive pulmonary fibrosis, which leads to delayed diagnosis. Aim.
Evgeniy I. Shchepikhin   +5 more
doaj   +1 more source

MYCOBACTERIOSIS IN THE PRACTICE OF PULMONOLOGISTS AND PHTHISIOLOGISTS

open access: yesТуберкулез и болезни лёгких, 2016
Goal of the study: to investigate the frequency of mycobacteriosis in the practice of pulmonologists and phthisiologists.Materials and methods. The analysis included medical files of 156 patients with various non-specific respiratory diseases and ...
A. E. Ergeshov   +5 more
doaj   +1 more source

A CLINICAL CASE OF DISSEMINATED PULMONARY LESIONS WITH A CONCURRENT CONDITION

open access: yesТуберкулез и болезни лёгких, 2018
The article presents a clinical case of a complex differential diagnostics of disseminated pulmonary lesions with a concurrent condition.
Anzhela S. Polyakova   +5 more
doaj   +1 more source

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

open access: yesBMC Public Health, 2021
Background BPaL, a 6 month oral regimen composed of bedaquiline, pretomanid, and linezolid for treating extensively drug-resistant tuberculosis (XDR-TB) is a potential alternative for at least 20 months of individualized treatment regimens (ITR). The ITR
S. E. J. van de Berg   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy